Concert Pharmaceuticals, Inc. Announces Closing Of Initial Public Offering

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

LEXINGTON, Mass.--(BUSINESS WIRE)--Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced the closing of its initial public offering of 6,000,000 shares of its common stock at a public offering price of $14.00 per share, before underwriting discounts.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC